The Global Cancer Immunotherapy Market is valued at US$153.30 billion in 2025 and is expected to reach US$324.89 billion by 2034, expanding at a CAGR of 8.6% from 2025 to 2034. Growing adoption of immune-based cancer treatments, personalized therapies, and combination approaches is supporting market expansion.
Cancer Immunotherapy Market Overview
Cancer immunotherapy includes treatments that...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)